LSL Pharma Group (TSXV:LSL) Scaled Net Operating Assets : 0.93 (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

LSL Pharma Group's operating assets for the quarter that ended in Sep. 2024 was C$37.79 Mil. LSL Pharma Group's operating liabilities for the quarter that ended in Sep. 2024 was C$3.54 Mil. LSL Pharma Group's Total Assets for the quarter that ended in Jun. 2024 was C$36.95 Mil. Therefore, LSL Pharma Group's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.93.

LSL Pharma Group Scaled Net Operating Assets Historical Data

The historical data trend for LSL Pharma Group's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group Scaled Net Operating Assets Chart

LSL Pharma Group Annual Data

Trend

Sep20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

0.74

0.97

0.69

0.91

LSL Pharma Group Quarterly Data
	Sep20	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial										0.80	0.84	0.94	1.00	0.93

Competitive Comparison of LSL Pharma Group's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, LSL Pharma Group's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LSL Pharma Group's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, LSL Pharma Group's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where LSL Pharma Group's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

LSL Pharma Group Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

LSL Pharma Group's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(30.892	-	5.976)	/	27.312
=	0.91

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	30.9	-	0.008
=	30.892

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	22.245	-	7.171	-	9.098
=	5.976

LSL Pharma Group's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Jun. 2024 )
=	(37.792	-	3.544)	/	36.951
=	0.93

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	37.956	-	0.164
=	37.792

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	17.587	-	9.091	-	4.952
=	3.544

LSL Pharma Group Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

540 d’Avaugour Street, Suite 1800, Boucherville, QC, CAN, J4B 0G6

Website

https://www.laboratoirelsl.com

LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group Headlines

No Headlines